1. Home
  2. TNL vs RYTM Comparison

TNL vs RYTM Comparison

Compare TNL & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNL
  • RYTM
  • Stock Information
  • Founded
  • TNL 1990
  • RYTM 2008
  • Country
  • TNL United States
  • RYTM United States
  • Employees
  • TNL N/A
  • RYTM N/A
  • Industry
  • TNL Hotels/Resorts
  • RYTM Biotechnology: Pharmaceutical Preparations
  • Sector
  • TNL Consumer Discretionary
  • RYTM Health Care
  • Exchange
  • TNL Nasdaq
  • RYTM Nasdaq
  • Market Cap
  • TNL 3.6B
  • RYTM 3.2B
  • IPO Year
  • TNL N/A
  • RYTM 2017
  • Fundamental
  • Price
  • TNL $46.28
  • RYTM $52.97
  • Analyst Decision
  • TNL Buy
  • RYTM Strong Buy
  • Analyst Count
  • TNL 10
  • RYTM 12
  • Target Price
  • TNL $63.70
  • RYTM $68.58
  • AVG Volume (30 Days)
  • TNL 756.8K
  • RYTM 521.7K
  • Earning Date
  • TNL 04-23-2025
  • RYTM 05-06-2025
  • Dividend Yield
  • TNL 4.84%
  • RYTM N/A
  • EPS Growth
  • TNL 10.24
  • RYTM N/A
  • EPS
  • TNL 5.82
  • RYTM N/A
  • Revenue
  • TNL $3,864,000,000.00
  • RYTM $130,126,000.00
  • Revenue This Year
  • TNL $5.41
  • RYTM $45.46
  • Revenue Next Year
  • TNL $4.49
  • RYTM $63.04
  • P/E Ratio
  • TNL $7.96
  • RYTM N/A
  • Revenue Growth
  • TNL 3.04
  • RYTM 68.06
  • 52 Week Low
  • TNL $39.91
  • RYTM $35.17
  • 52 Week High
  • TNL $58.95
  • RYTM $68.58
  • Technical
  • Relative Strength Index (RSI)
  • TNL 33.82
  • RYTM 48.25
  • Support Level
  • TNL $45.63
  • RYTM $52.54
  • Resistance Level
  • TNL $49.47
  • RYTM $55.21
  • Average True Range (ATR)
  • TNL 1.48
  • RYTM 2.09
  • MACD
  • TNL -0.07
  • RYTM 0.37
  • Stochastic Oscillator
  • TNL 29.63
  • RYTM 49.48

About TNL Travel Leisure Co. Common Stock

Travel+Leisure Co is a membership and leisure travel company. It provides hospitality services and travel products. The company operates in the segments of Vacation Ownership, which is the key revenue-driving segment, develops, markets and sells vacation ownership interests (VOIs) to individual consumers, provides consumer financing in connection with the sale of VOIs, and provides property management services at resorts and Travel and Membership which operates a variety of travel businesses, including three vacation exchange brands, a home exchange network, travel technology platforms, travel memberships, and direct-to-consumer rentals. The majority of the revenue is earned from the United States.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

Share on Social Networks: